SCHEMBL21495073

SCHEMBL21495073

O=C[C@@H](Br)c1ccccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 2/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
NPSR1 Q6W5P4 1/20 0.43
GSK3B P49841 1/20 0.41
KDM4E B2RXH2 3/20 0.41
KCNA5 P22460 5/20 0.40
KCNE1 P15382 2/20 0.40
TSHR P16473 2/20 0.40
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 3/20 0.39
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
ATM Q13315 1/20 0.38
KCNH2 Q12809 1/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP2C19 P33261 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL542583 1.00 SLC6A3 (0.45) SLC6A3SLC6A2SLC6A4NPSR1GSK3B
Bromide SCHEMBL22094891 0.98 SLC6A3 (0.44) SLC6A3SLC6A2SLC6A4NPSR1GSK3B
Bromide SCHEMBL1696091 0.98 SLC6A3 (0.44) SLC6A3SLC6A2SLC6A4NPSR1GSK3B
Propionic Acid SCHEMBL28356667 0.85 ALDH1A1 (0.52) SLC6A3SLC6A2SLC6A4NPSR1GSK3B
SCHEMBL11034374 0.79 SLC6A2 (0.45) SLC6A3SLC6A2SLC6A4NPSR1GSK3B
SCHEMBL225565 0.78 SLC6A3 (0.48) SLC6A3SLC6A2SLC6A4NPSR1KDM4E
SCHEMBL4099842 0.78
SCHEMBL9185638 0.77 SLC6A3 (0.56) SLC6A3SLC6A2SLC6A4NPSR1GSK3B
SCHEMBL11877966 0.75 KDM4E (0.49) SLC6A3SLC6A2SLC6A4NPSR1GSK3B
SCHEMBL4420495 0.75 SLC6A3 (0.45) SLC6A3SLC6A2SLC6A4NPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
EP-4161921-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF Anima Biotech Inc. (US) 2023-04-12 EP disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed
WO-2021252555-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF ANIMA BIOTECH INC. (US) 2021-12-16 WO disclosed
WO-2019201865-A1 SUBSTITUTED AMINOTHIAZOLES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2019-10-24 WO disclosed
WO-2019201867-A1 SUBSTITUTED PROPANAMIDES AS INHIBITORS OF NUCLEASES MASARYKOVA UNIVERZITA (CZ) 2019-10-24 WO disclosed